Roberts, M H

Economic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies. [electronic resource] - Expert review of pharmacoeconomics & outcomes research 2016 - 167-92 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1744-8379

10.1586/14737167.2016.1148602 doi


Bronchodilator Agents--economics
Cost-Benefit Analysis
Fluticasone-Salmeterol Drug Combination--economics
Humans
Pulmonary Disease, Chronic Obstructive--drug therapy
Treatment Outcome